Gyrate Atrophy clinical trials at UCSF

1 research study open to eligible people

Gyrate atrophy is a genetic disorder that affects vision by damaging the retina. UCSF is exploring the relationship between ornithine levels and eye health in this condition. The trials aim to map how the disease changes over time.

Showing trials for

  • Gyrate Atrophy Ocular and Systemic Study

    open to eligible people ages 12 years and up

    The Gyrate Atrophy Ocular and Systemic Study characterizes the natural history of ornithine levels and retinal degeneration (RD) associated with disease-causing OAT variants in the presence of standard care dietary treatment regimens over 4 years. The research goal is to understand the impact of OAT mutations on plasma ornithine levels and retinal degeneration. Funding Source- FDA OOPD

    San Francisco, California and other locations

Last updated: